相似文献
1
Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients.
J Neurol Neurosurg Psychiatry. 1988 Jul;51(7):929-33. doi: 10.1136/jnnp.51.7.929.
2
Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
Arch Neurol. 1990 Aug;47(8):888-92. doi: 10.1001/archneur.1990.00530080072013.
3
The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.
J Psychopharmacol. 2003 Sep;17(3):269-72. doi: 10.1177/02698811030173007.
4
Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients.
Br J Clin Pharmacol. 1992 Jan;33(1):111-4. doi: 10.1111/j.1365-2125.1992.tb04009.x.
5
[Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
Rev Invest Clin. 2005 Jul-Aug;57(4):522-31.
6
Cognitive function in adult epileptic patients established on anticonvulsant monotherapy.
Epilepsy Res. 1990 Dec;7(3):219-25. doi: 10.1016/0920-1211(90)90018-q.
7
Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.
Eur J Clin Pharmacol. 1986;31(2):195-9. doi: 10.1007/BF00606658.
8
Dose-dependent metabolism of carbamazepine in humans.
Epilepsy Res. 1996 Jul;24(3):163-72. doi: 10.1016/0920-1211(96)00011-3.
9
The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
Epilepsy Behav. 2009 Mar;14(3):522-8. doi: 10.1016/j.yebeh.2008.11.012. Epub 2008 Dec 25.
10
Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.
Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):417-21. doi: 10.1007/BF00606558.
引用本文的文献
1
Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration.
Curr Neuropharmacol. 2023;21(8):1736-1754. doi: 10.2174/1570159X21666230504160948.
2
Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges.
Neuropsychiatr Dis Treat. 2016 Feb 9;12:287-96. doi: 10.2147/NDT.S81549. eCollection 2016.
3
Add-on Effect of Levetiracetam on Cognitive Activity of Carbamazepine and Topiramate Treated Healthy Rats.
J Clin Diagn Res. 2015 Jun;9(6):FF01-4. doi: 10.7860/JCDR/2015/12654.6110. Epub 2015 Jun 1.
4
The cognitive impact of antiepileptic drugs.
Ther Adv Neurol Disord. 2011 Nov;4(6):385-407. doi: 10.1177/1756285611417920.
5
Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):372-6. doi: 10.1136/jnnp.62.4.372.
6
Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.
Br J Clin Pharmacol. 1993 Sep;36(3):257-61. doi: 10.1111/j.1365-2125.1993.tb04226.x.
7
Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.
Clin Pharmacokinet. 1996 Dec;31(6):470-93. doi: 10.2165/00003088-199631060-00005.
8
Seizure prophylaxis for brain tumour patients. Brief review and guide for family physicians.
Can Fam Physician. 1993 May;39:1153-6, 1159-60, 1163-4.
9
Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy.
J Neurol Neurosurg Psychiatry. 1993 Dec;56(12):1271-5. doi: 10.1136/jnnp.56.12.1271.
10
Antiepileptic drugs. A review of clinically significant drug interactions.
Drug Saf. 1993 Sep;9(3):156-84. doi: 10.2165/00002018-199309030-00003.
本文引用的文献
1
A survey of epilepsy in fourteen general practices. II. Social and psychological aspects.
Epilepsia. 1960 Apr;1:285-99. doi: 10.1111/j.1528-1157.1959.tb04266.x.
2
Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma.
Ther Drug Monit. 1981;3(1):63-70.
3
Anticonvulsant drugs and cognitive functions.
Epilepsia. 1982 Oct;23(5):531-44. doi: 10.1111/j.1528-1157.1982.tb05439.x.
4
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response.
Arch Gen Psychiatry. 1983 Jun;40(6):673-6. doi: 10.1001/archpsyc.1983.04390010083010.
5
Effect of reduction of anticonvulsants on wellbeing.
Br Med J (Clin Res Ed). 1982 Aug 7;285(6339):423-4. doi: 10.1136/bmj.285.6339.423.
6
Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia.
Arch Neurol. 1984 Jun;41(6):598-601. doi: 10.1001/archneur.1984.04210080006004.
7
Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
Br J Clin Pharmacol. 1983 Dec;16(6):747-9. doi: 10.1111/j.1365-2125.1983.tb02257.x.
8
Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report.
Br J Psychiatry. 1974 May;124(0):440-5. doi: 10.1192/bjp.124.5.440.
9
An improvement in cognitive function following polypharmacy reduction in a group of epileptic patients.
Acta Neurol Scand. 1985 Jun;71(6):448-52. doi: 10.1111/j.1600-0404.1985.tb03227.x.
10
A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy.
Epilepsia. 1986 Mar-Apr;27(2):128-34. doi: 10.1111/j.1528-1157.1986.tb03515.x.
Zotero 插件